Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-067005

Director bought 2,202 shares at $13.19 ($29,044)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Manning Paul B Director 2021-11-24 Purchase +2,202 $13.19 $29,044 34,202 D
Open-market purchases · 2,202 sh · avg $13.19 · $29,044
Loading xslF345X03/doc4.xml…